FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is offered is a pharmaceutical composition for local application in gynaecology and containing therapeutically effective amounts of ornidazole, neomycin or gentamycin, an anti-inflammatory ingredient specified in a group of glucocorticosteroids, and an antimycotic ingredient specified in imidazole derivatives.
EFFECT: invention provides producing a new preparation for intravaginal therapy of infectious-inflammatory and disbiotic genital diseases in females.
5 cl, 8 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
| VAGINAL SUPPOSITORY | 2006 |
|
RU2320319C1 |
| UROGENITAL INFECTION TREATMENT DRUG | 2003 |
|
RU2253457C2 |
| METHOD OF TREATING MICROBIAL ECZEMA | 2018 |
|
RU2699655C1 |
| VAGINAL COMPOSITIONS FOR INFECTION TREATMENT | 2005 |
|
RU2385720C2 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC AND INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2440108C2 |
| VAGINAL SUPPOSITORIES POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANALGESIC, ANTIPRURITIC ACTION | 2019 |
|
RU2729647C1 |
